CALIFORNIA TECH

California Biotech News

For readers in California, this page covers gene editing, drug development and genomics. Reporting follows clinical trials, biotech financing and the approvals that move treatments toward patients.


Recent news


More in Biotech

California biotech reporting spans the gene therapy and CRISPR programs in development, drug approvals, biotech IPOs and acquisitions, and the genomics research that reaches commercial use. Coverage reaches from the Bay Area and San Diego research corridors to the Central Valley and the state's smaller life sciences hubs. Clinical trial design often gets as much scrutiny as the headline result, since the two are easily conflated. Financing cycles and regulatory timelines are the two forces that shape which programs advance and which stall.